Brief: Peak Bio Receives Determination Letter From Nasdaq To Delist Company’S Common Stock And Warrants
09/01/2023 12:01
Jan 9 (Reuters) - Peak Bio Inc PKBO.O :
* PEAK BIO INC - ON JANUARY 6, 2023 CO RECEIVED
DETERMINATION
LETTER FROM NASDAQ TO DELIST THE COMPANY’S COMMON STOCK AND
WARRANTS
Source text : (https://bit.ly/3Iz0TMQ)
Further company coverage: PKBO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Peak Bio
See all newsBrief: Akari Therapeutics Announces Shareholder Approval In Connection With Peak Bio Merger
Brief: Akari Therapeutics And Peak Bio Announce Portfolio Prioritization Plan For Combined Go-Forward Merger Entity
Brief: Peak Bio, Inc. Announces Up-Listing To Otcqb Market
Brief: Peak Bio Announces Its Application To Uplist To The Otcqb Venture Market
Brief: Peak Bio, Inc. Announces Amendment And Continued Access To Equity Line Of Up To $100 Million USD Via An Accelerated Common Stock Purchase Transaction With White Lion Capital